135 studies found for:    epigenetics
Show Display Options
Rank Status Study
21 Recruiting Epigenetic Regulation of BDNF in Major Depression
Condition: Major Depressive Disorder
Intervention:
22 Recruiting Epigenetic and Developmental Effects of In Utero Exposure to Environmental Toxicants
Conditions: Full Term Infants;   Environmental Exposures;   Adiposity
Intervention:
23 Completed Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML
Condition: Acute Myeloid Leukemia
Intervention: Drug: decitabine
24 Active, not recruiting Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Condition: Pediatric Acute Myelogenous Leukemia (AML)
Intervention: Drug: Decitabine
25 Completed Behavioral, Genetic, and Epigenetic Implications of Dietary Supplementation With Alpha-linolenic Acid in Humans
Condition: Effect of Fatty Acids on Memory Performance of Toddlers
Interventions: Dietary Supplement: Flaxseed oil;   Dietary Supplement: corn oil
26 Completed Open-label Study of Curcumin C-3 Complex in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Depression
Intervention: Dietary Supplement: Super-Curcumin
27 Terminated Open Label Study to Evaluate the Safety, Efficacy, Viral Kinetics, Genetic, Epigenetic, and Proteomic Expression of Weekly Peginterferon Alpha 2a and Ribavirin Therapy for Chronic Hepatitis C in Latino Subjects With and Without HIV Co-infection
Conditions: Hepatitis C;   HIV
Intervention: Drug: Pegylated interferon with ribavirin
28 Recruiting Biomarkers for Breast Cancer Risk in African American Women
Condition: Breast Cancer
Intervention:
29 Recruiting Genetics and Markers of Degenerative and Inflammatory Eye Diseases
Conditions: Diabetic Retinopathy;   Age-Related Macular Degeneration (AMD);   Uveitis
Intervention:
30 Not yet recruiting Epigenetic Testing for Breast Cancer Risk Stratification
Condition: Breast Cancer
Intervention:
31 Unknown  Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Malignant Neoplasm of Cardio-esophageal Junction of Stomach
Interventions: Drug: Azacitidine;   Drug: Oxaliplatin;   Drug: Epirubicin;   Drug: Capecitabine
32 Completed A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression
Conditions: Depression;   Depression Secondary to Other Disease
Intervention: Drug: Escitalopram
33 Active, not recruiting Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma
Conditions: Follicular Lymphoma;   Marginal Zone Lymphoma
Interventions: Drug: azacitidine;   Drug: lenalidomide
34 Recruiting Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Condition: Diffuse Large B-cell Lymphoma
Interventions: Drug: RAD001;   Drug: LBH589;   Drug: RAD001 and LBH589 as a doublet
35 Terminated A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Condition: Acute Myelogenous Leukemia (AML)
Interventions: Drug: decitabine Induction Chemotherapy;   Drug: Induction Chemotherapy
36 Unknown  To Investigate the Influence of Ethnicity in Metabolic Disease in Healthy, Overweight and Obese Subjects
Conditions: Healthy;   Overweight;   Obesity
Intervention:
37 Recruiting Gene Promoter DNA Methylations and Their Relationships With Endophenotypes in Patients With Schizophrenia
Condition: Schizophrenia
Intervention:
38 Unknown  Hydralazine Valproate for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Hydralazine and magnesium valproate;   Drug: Placebo
39 Recruiting An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis
Condition: Oestrogen Receptor Positive Advanced Breast Cancer
Interventions: Drug: RAD001;   Drug: Exemestane
40 Not yet recruiting Administrating Oxytocin to Treat Treatment Schizophrenia and Schizo-affective Patients
Conditions: Oxytocin + Non Specific Counselling;   Oxytocin + Social Skills Training;   Placebo + Non Specific Counselling;   Placebo + Social Skills Training
Interventions: Drug: Oxytocin;   Behavioral: Social Skills Training;   Behavioral: Placebo + Non Specific Counselling

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years